JFL
AVNS icon

Jarislowsky, Fraser Ltd’s Avanos Medical AVNS Stock Holding History

Jarislowsky, Fraser Ltd’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,556
Closed -$201K – 215
2018
Q3 		$201K Sell
3,556
-658
-16% -$42.3K ﹤0.01% 202
2018
Q2 		$241K Buy
+4,214
New +$223K ﹤0.01% 204
2018
Q1 		– Sell
-4,398
Closed -$203K – 218
2017
Q4 		$203K Sell
4,398
-62
-1% -$2.85K ﹤0.01% 223
2017
Q3 		$200K Buy
+4,460
New +$190K ﹤0.01% 222
2017
Q1 		– Sell
-6,585
Closed -$243K – 200
2016
Q4 		$243K Buy
+6,585
New +$235K ﹤0.01% 185

Other funds holding AVNS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return